BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 79 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,229 | -90.3% | 16,138 | 0.0% | 0.00% | – |
Q2 2023 | $33,244 | -28.0% | 16,138 | +15.3% | 0.00% | – |
Q1 2023 | $46,174 | +9.6% | 13,992 | -45.5% | 0.00% | – |
Q4 2022 | $42,117 | -69.0% | 25,681 | -16.3% | 0.00% | – |
Q3 2022 | $136,000 | -17.1% | 30,681 | -15.3% | 0.00% | – |
Q4 2020 | $164,000 | -62.7% | 36,202 | +39.2% | 0.00% | -100.0% |
Q3 2020 | $440,000 | +26.4% | 26,002 | -16.1% | 0.00% | 0.0% |
Q2 2020 | $348,000 | +11500.0% | 31,002 | +3000.2% | 0.00% | – |
Q4 2016 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
Q1 2016 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2015 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2015 | $2,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2015 | $4,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,500 | $825,000 | 0.55% |
SABBY MANAGEMENT, LLC | 136,484 | $27,310 | 0.02% |
LIBERTY WEALTH MANAGEMENT LLC | 352,619 | $71 | 0.02% |
Weaver Consulting Group | 99,356 | $19,881 | 0.01% |
ABNER HERRMAN & BROCK LLC | 145,500 | $29 | 0.00% |
JMAC ENTERPRISES LLC | 65,430 | $13,093 | 0.00% |
Professional Financial Advisors, LLC | 17,279 | $3,458 | 0.00% |
Ikarian Capital, LLC | 90,242 | $18,057 | 0.00% |
MOORE CAPITAL MANAGEMENT, LP | 200,000 | $40,020 | 0.00% |
Weaver Consulting Group | 45,000 | $2,750 | 0.00% |